Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

U.S. Orthobiologics Market Analysis - COVID19 - 2019-2025 - MedSuite - Includes: Bone Graft Substitutes, Cellular Allografts, Growth Factors, Orthopedic Cell Therapy, Hyaluronic Acid Viscosupplementation & Orthopedic Cartilage Repair Devices

Published by iData Research Inc. Product code 1000911
Published Content info 478 Pages
Delivery time: 1-2 business days
Price
Back to Top
U.S. Orthobiologics Market Analysis - COVID19 - 2019-2025 - MedSuite - Includes: Bone Graft Substitutes, Cellular Allografts, Growth Factors, Orthopedic Cell Therapy, Hyaluronic Acid Viscosupplementation & Orthopedic Cartilage Repair Devices
Published: March 19, 2021 Content info: 478 Pages
Description

Throughout this medical market research, the publisher analyzed 47+ Orthobiologics companies in the United States and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this report suite report contains all of the U.S. Orthobiologics market analysis, each of the market segments is also available as a stand-alone a report, MedCore.

Markets Covered

  • Bone Graft Substitutes Market - MedCore
  • Growth Factors Market - MedCore
  • Cellular Allografts Market - MedCore
  • Orthopedic Cell Therapy Devices Market - MedCore
  • Hyaluronic Acid Viscosupplementation Devices Market - MedCore
  • Orthopedic Cartilage Repair Devices Market - MedCore

U.S. Orthobiologics Market Insights

Overall, the U.S. orthopedic biomaterials market was valued at $3.1 billion in 2020. This is expected to increase over the forecast period to reach over $5 billion in 2025.

A particular trend in the U.S. orthopedic biomaterials market is competitors that are seeking to penetrate high-growth segments outside their traditional space by distributing existing products manufactured by other companies, rather than creating their own. This often involves partnering with a company by taking on the costs associated with regulation and market approval, in exchange for exclusive market rights. The distributor then pays the manufacturer in royalties. The goal is to penetrate the high-growth segments and build or strengthen networks before the segment matures. This is especially the case for competitors in segments that are in decline, such as competitors in the five-injection hyaluronic acid treatment.

Medtronic leads the U.S. orthopedic biomaterials market. They have the largest share in the bone graft substitute segment and had their dominating product, INFUSE™ in the growth factor market. This company's growth has been recovering since the negative media attention and lawsuits regarding off-label usage of its growth factor bone morphogenetic protein (BMP) product, INFUSE®, which accounts for a significant portion of the company's revenue in biologic therapy.

Table of Contents
Product Code: iDATA_USOB19_MS

TABLE OF CONTENT

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

IMPACT OF COVID-19 ON THE U.S. ORTHOPEDIC BIOMATERIALS MARKET

  • 2.1 INTRODUCTION
    • Treatable Population and the SARS-CoV-2 Virus
  • 2.2 ANALYSIS BY MARKET SEGMENT
    • Best Case Scenario
    • Base Case Scenario
    • Worst Case Scenario

PRODUCT ASSESSMENT

  • 3.1 INTRODUCTION
  • 3.2 PRODUCT PORTFOLIOS
    • Bone Graft Substitutes
    • Growth Factors
    • Other products
    • Cellular Allografts (Stem Cell)
    • Cell Therapy
    • Platelet-Rich Plasma
    • Concentrated Bone Marrow Aspirate
    • Hyaluronic Acid Viscosupplementation (HAV)
    • Cartilage Repair
  • 3.3 REGULATORY ISSUES AND RECALLS
    • Bone Graft Substitutes
    • Allografts
    • MTF
    • DBM
    • AlloSource
    • SeaSpine
    • RTI Surgical
    • Synthetics
    • Abyrx
    • Zimmer Biomet
    • Growth Factors
    • Medtronic
    • Cell Therapy
    • Bone Marrow Cell Therapy
    • Argon Medical Devices
    • Stryker
    • Teleflex
    • Hyaluronic Acid Viscosupplementation
    • Three-injection
    • Ferring Pharmaceuticals
    • Cartilage Repair
    • Smith & Nephew
    • Richard Wolf
  • 3.4 CLINICAL TRIALS
    • Bone Graft Substitutes
    • Allografts
    • Providence Medical Technology
    • The University of Texas Health Science
    • University of Winchester
    • BDM
    • K2M
    • Zimmer Biomet
    • Synthetics
    • Baxter
    • Bonesupport
    • DePuy Synthes
    • NuVasive
    • RTI surgical
    • Sunstar GUIDOR
    • Other materials and comparison
    • Seoul National University Hospital.
    • Sewon Cellontech
    • SurgaColl Technologies Limited
    • University of Colorado

TABLE OF CONTENTS

  • University of Padova
  • Growth Factors
  • Bioventus
  • Cerapedics
  • CGBio
  • Isto
  • Medtronic
  • NuVasive
  • Wright
  • Others
  • Cellular Allografts (Stem Cell)
  • Cervical
  • DePuy Synthes
  • Virginia Spine Institute
  • Lumbar
  • RTI Surgical
  • Trinity Stem Cell Institute
  • Spinal Cord
  • AFBMTC
  • Stem Cells Arabia
  • Pharmicell
  • Knee, Foot, Ankle, Tibial
  • Medipost
  • Nantes University Hospital
  • Royan Institute
  • Red de Terapia Celular
  • RTI Surgical
  • University of Jordan
  • Cell Therapy
  • Bone Marrow Cell Therapy
  • Centre of Postgraduate Medical Education
  • New York University

TABLE OF CONTENTS

  • Stempeutics Research
  • Royan Institute
  • Universidad Autonoma de Madrid
  • Vericel (Aastrom Bioscience)
  • Platelet-Rich Cell Therapy
  • Assistance Publique Hopitaux De Marseille
  • Assiut University
  • Brian Walters
  • Hospital for Special Surgery
  • Istituto Ortopedico Rizzoli
  • Rio de Janeiro State University
  • Tri-Service General Hospital
  • University of California
  • Others
  • Hyaluronic Acid Viscosupplementation
  • Anika Therapeutics
  • Bioventus
  • Cario University
  • Ferring Pharmaceuticals
  • Federal University of Minas Gerais
  • Fidia Pharma USA Inc.
  • Istituto Ortopedico Rizzoli
  • University Hospital
  • Universidade Nova de Lisboa
  • Cartilage Repair
  • Autologous Chondrocyte Implantation
  • BioGend (Exactech)
  • Histogenics
  • ISTO and Zimmer Biomet
  • Shetty-Kim Research Foundation
  • Meniscal Allograft
  • Orthox
  • Microfracture Adjunct
  • Anika Therapeutics
  • Aesculap Biologics
  • Sewon Cellontech
  • Smith & Nephew
  • Osteochondral Allograft
  • TBF Genie Tissulaire
  • Particulated Juvenile Cartilage
  • Zimmer Biomet

U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

  • 4.1 INTRODUCTION
    • Bone Graft Substitutes
    • Growth Factors
    • Cellular Allografts
    • Cell Therapies
    • Hyaluronic Acid (HA) Viscosupplementation
    • Cartilage Repair
  • 4.2 MARKET OVERVIEW
  • 4.3 TREND ANALYSIS BY SEGMENT
  • 4.4 DRIVERS AND LIMITERS
    • Market Drivers
    • Market Limiters
  • 4.5 COMPETITIVE MARKET SHARE ANALYSIS
  • 4.6 MERGERS AND ACQUISITIONS
  • 4.7 COMPANY PROFILES
    • Anika Therapeutics
    • Bioventus
    • DePuy Synthes
    • Ferring Pharmaceuticals
    • Fidia Pharmaceuticals
    • Genzyme (Sanofi Group)
    • Harvest Technologies (Terumo BCT)
    • Integra LifeSciences
    • Medtronic
    • Musculoskeletal Transplant Foundation (MTF)
    • NuVasive
    • Orthofix
    • RTI Surgical
    • Stryker
    • Vericel Corporation (formerly Aastrom Bioscience)
    • Zimmer Biomet
  • 4.8 SWOT ANALYSIS
    • Anika Therapeutics
    • Bioventus
    • DePuy Synthes
    • Ferring Pharmaceuticals
    • Fidia Pharmaceuticals
    • Harvest Technologies (Terumo BCT)
    • Integra LifeSciences
    • Medtronic
    • Musculoskeletal Transplant Foundation (MTF)
    • NuVasive
    • Orthofix
    • Stryker
    • Vericel Corporation (formerly Aastrom Bioscience)
    • Zimmer Biomet

PROCEDURE NUMBERS

  • 5.1 INTRODUCTION
  • 5.2 PROCEDURES
    • Total Orthopedic Biomaterial Procedures by Segment
    • Orthopedic Bone Grafting Procedures
    • Orthopedic Bone Grafting Procedures by Material
    • Autograft Procedures by Indication
    • Allograft Procedures by Indication
    • DBM Procedures by Indication
    • Synthetic Procedures by Indication
    • Orthopedic Bone Grafting Procedures by Indication
    • Average Units Used per Procedure by Indication
    • Orthopedic Growth Factor Procedures
    • Orthopedic Growth Factor Procedures by Indication
    • Cellular Allograft Procedures
    • Cellular Allograft Procedures by Anatomy
    • Orthopedic Cell Therapy Procedures
    • Orthopedic Cell Therapy Procedures by Type
    • Platelet-Rich Plasma Procedures by Indication
    • Bone Marrow Aspirate Concentrate Procedures by Indication
    • Hyaluronic Acid Supplementation Procedures
    • Hyaluronic Acid Supplementation Procedures by Injection Cycle
    • Orthopedic Cartilage Repair Procedures
    • Orthopedic Cartilage Repair Procedures by Type

ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET

  • 6.1 INTRODUCTION
    • Units per Procedure by Indication
  • 6.2 MARKET OVERVIEW
    • Orthopedic Bone Graft Substitute Market by Material
    • Orthopedic Bone Graft Substitute Market by Indication
  • 6.3 MARKET ANALYSIS AND FORECAST
    • Orthopedic Bone Graft Substitute Market by Material
    • Total Allograft Bone Graft Substitute Market
    • Allograft Bone Graft Substitute Market by Indication
    • Total Demineralized Bone Matrix Allograft Bone Graft Substitute Market
    • DBM with Carriers Market
    • DBM without Carriers Market
    • Demineralized Bone Matrix Allograft Bone Graft Substitute Market by Indication
    • Total Synthetic Bone Graft Substitute Market
    • Synthetic Bone Graft Substitute Market by Indication
    • Orthopedic Bone Graft Substitute Market by Indication
    • Spine Bone Graft Substitute Market
    • Cervical Spine Bone Graft Substitute Market
    • Thoracolumbar Spine Bone Graft Substitute Market
    • Trauma Bone Graft Substitute Market
    • Non-Union Trauma Bone Graft Substitute Market
    • Fresh Fracture Trauma Bone Graft Substitute Market
    • Large Joint Reconstruction Bone Graft Substitute Market
    • Hip Reconstruction Bone Graft Substitute Market
    • Knee Reconstruction Bone Graft Substitute Market
    • Foot Reconstruction Bone Graft Substitute Market
    • Craniomaxillofacial Bone Graft Substitute Market
    • Oncology Bone Graft Substitute Market
  • 6.4 DRIVERS AND LIMITERS
    • Allograft Market
    • Market Drivers
    • Market Limiters
    • Demineralized Bone Matrix Bone Graft Substitute Market
    • Market Drivers
    • Market Limiters
    • Synthetic Bone Graft Substitute Market
    • Market Drivers
    • Market Limiters
  • 6.5 COMPETITIVE MARKET SHARE ANALYSIS

ORTHOPEDIC GROWTH FACTOR MARKET

  • 7.1 INTRODUCTION
    • BMP-2 (Medtronic)
    • PDGF-BB (Wright Medical)
    • BMP-7 (Ember Therapeutics)
    • P-15 Synthetic Small Peptide (Cerapedics)
  • 7.2 MARKET ANALYSIS AND FORECAST
  • 7.3 DRIVERS AND LIMITERS
    • Market Drivers
    • Market Limiters
  • 7.4 COMPETITIVE MARKET SHARE ANALYSIS

CELLULAR ALLOGRAFT MARKET

  • 8.1 INTRODUCTION
    • Lineage
    • Human Embryonic Stem Cells (hESC)
    • Mesenchymal Stem Cells (MSC)
    • Other Therapeutic Applications
  • 8.2 MARKET OVERVIEW
  • 8.3 MARKET ANALYSIS AND FORECAST
    • Total Cellular Allograft Market
    • Cervical Spine Cellular Allograft Market
    • Lumbar Spine Cellular Allograft Market
  • 8.4 DRIVERS AND LIMITERS
    • Market Drivers
    • Market Limiters
  • 8.5 COMPETITIVE MARKET SHARE ANALYSIS

ORTHOPEDIC CELL THERAPY MARKET

  • 9.1 INTRODUCTION
  • 9.2 MARKET OVERVIEW
  • 9.3 MARKET ANALYSIS AND FORECAST
    • Platelet-Rich Plasma Market
    • Soft Tissue Platelet-Rich Plasma Market
    • Orthopedic Platelet-Rich Plasma Market
    • Cardiac Platelet-Rich Plasma Market
    • Spine Platelet-Rich Plasma Market
    • Plastics Platelet-Rich Plasma Market
    • Bone Marrow Aspirate Concentrate Market
    • Spine Bone Marrow Aspirate Concentrate Market
    • Trauma Bone Marrow Aspirate Concentrate Market
    • Orthopedic Soft Tissue Bone Marrow Aspirate Concentrate Market
    • Joint Reconstruction Bone Marrow Aspirate Concentrate Market
  • 9.4 DRIVERS AND LIMITERS
    • Market Drivers
    • Market Limiters
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 10.1 INTRODUCTION
    • Benefits of Viscosupplementation
    • Synovial Fluid
    • Product Types
    • Single-Injection Products
    • Two-Injection Cycle Products
    • Three-Injection Cycle Products
    • Three/Five-Injection Cycle Products
    • Reimbursement
  • 10.2 MARKET OVERVIEW
  • 10.3 MARKET ANALYSIS AND FORECAST
    • Total Hyaluronic Acid Viscosupplementation Market
    • Single-Injection Hyaluronic Acid Viscosupplementation Market
    • Two-Injection Hyaluronic Acid Viscosupplementation Market
    • Three-Injection Hyaluronic Acid Viscosupplementation Market
    • Five-Injection Hyaluronic Acid Viscosupplementation Market
  • 10.4 DRIVERS AND LIMITERS
    • Market Drivers
    • Market Limiters
  • 10.5 COMPETITIVE MARKET SHARE ANALYSIS

ORTHOPEDIC CARTILAGE REPAIR MARKET

  • 11.1 INTRODUCTION
    • Anatomy
    • Methods for Cartilage Repair
    • Microfracture
    • Microfracture Adjunct
    • Osteoarticular Autograft Transfer System
    • Particulated Juvenile Allograft
    • Osteochondral Allograft Transfer
    • Autologous Chondrocyte Implantation
    • Meniscal Allograft Transplantation
  • 11.2 MARKET OVERVIEW
  • 11.3 MARKET ANALYSIS AND FORECAST
    • Osteochondral Allograft Market
    • Meniscal Allograft Market
    • Autologous Chondrocyte Implantation Market
    • Particulated Juvenile Allograft Market
    • Microfracture Adjunct Market
  • 11.4 DRIVERS AND LIMITERS
    • Market Drivers
    • Market Limiters
  • 11.5 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

Back to Top